 |
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement Nº 643056. For more information contact BIORAPID coordinator Prof. Jarka Glassey. |
The main objective of this ambitious ITN is to establish a pan-European training network providing essential training to Early Stage Researchers (ESRs) in methods of rapid bioprocess training with skills enabling them to integrate directly into European biopharmaceutical industry, increasing its competitiveness worldwide.
Biorapid uniquely brings the studies on efficacy, toxicity, immunogenicity and hypersensitivity into the process development by using new predictive modelling tools (as PAT tools) with the aim to support early screening of potential drug candidates. This provides a comprehensive scientific training to the ESRs in this area as well as providing the European biopharmaceutical industry with a valuable framework for future rapid bioprocess development.
| |
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement Nº 643056. For more information contact BIORAPID coordinator Prof. Jarka Glassey. |